本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

ADMA Biologics Inc

22.33
+0.60002.76%
盘后22.400.0700+0.31%19:57 EDT
成交量:217.13万
成交额:4,814.92万
市值:53.06亿
市盈率:27.57
高:22.37
开:21.82
低:21.80
收:21.73
数据加载中...
2022/05/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/25

重要事件披露

8-K - Current report
2022/03/24

重要事件披露

8-K - Current report
2022/03/24

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/09

重要事件披露

8-K - Current report
2022/03/07

重要事件披露

8-K - Current report
2022/03/07

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/15

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/04

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/01/19

重要事件披露

8-K - Current report
2022/01/18

重要事件披露

8-K - Current report
2021/12/30

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/12/21

重要事件披露

8-K - Current report
2021/10/26

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/26

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/26

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/10/26

持股变动声明

4 - Statement of changes in beneficial ownership of securities